Company Filing History:
Years Active: 1999-2011
Title: Innovations and Contributions of John Desmond Walsh
Introduction
John Desmond Walsh is a notable inventor based in Curl Curl, Australia. He has made significant contributions to the field of pharmaceuticals and veterinary formulations, holding a total of seven patents. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Walsh's latest patents include a bioimplant formulation comprising lecithin and stearin. This pharmaceutical and veterinary formulation contains about 2-30% (w/w) of at least one active agent, about 0.5-20.0% (w/w) of a pore-forming agent comprising lecithin and an organic salt, with the balance being stearin. Another significant patent is the sustained peptide-release formulation, which is designed for the sustained release of a peptide agonist or analogue. This formulation comprises about 2-15% (w/w) of at least one peptide agonist or analogue other than deslorelin, about 0.5-3.5% (w/w) lecithin, and the balance stearin. It is particularly beneficial for treating conditions where suppression of sex hormone levels is advantageous, such as prostate cancer, ovarian and breast cancer, and benign prostatic hyperplasia in dogs.
Career Highlights
Throughout his career, Walsh has worked with prominent companies such as Peptech Limited and Peptech Animal Health Pty Limited. His innovative approaches have led to advancements in the pharmaceutical industry, particularly in formulations that improve treatment outcomes.
Collaborations
Walsh has collaborated with notable individuals in his field, including Timothy Elliot Trigg and Paul Adam Schober. These partnerships have contributed to the development of his patented formulations and have enhanced the impact of his work.
Conclusion
John Desmond Walsh's contributions to pharmaceutical and veterinary formulations demonstrate his commitment to innovation and improving health outcomes. His patents reflect a deep understanding of the complexities involved in drug formulation and the importance of addressing critical health issues.